In this video we’re going to cover a common side effect of hormonal blockade (otherwise known as androgen deprivation or testosterone blockade). Men with low testosterone levels from therapy develop accelerated calcium loss from their bones. The consequences are something called Osteoporosis. When is progresses to a certain point men can develop unexpected fractures.

Hi, I’m Dr. Scholz, let’s talk about prostate cancer.

In today’s video we’re going to cover how to reduce the side effects of hormonal therapy when it’s used for the treatment of prostate cancer. Hormonal therapy has a variety of different names: Androgen Deprivation Therapy (ADT for short), Testosterone Inactivating Pharmaceuticals (TIP for short. Hormonal blockade comes in various forms and various intensities. I’m not going to try…

In this video we’re going to cover unorthodox treatments for High-Azure. That’s the high-grade type of prostate cancer—men that have been recently diagnosed, but have higher Gleason scores, have possibly lymph node spread in the pelvic region. These are situations that are

We always talk about stages of prostate cancer because the whole topic of prostate cancer is so vast that you gotta break it down into categories. The Azure category is actually a relatively small segment of prostate cancer which varies from harmless to people that have cancer that has spread or metastasized. Azure means someone that is newly diagnosed, but it appears that the disease is

Hi, I’m Dr. Scholz, I’m a medical oncologist who specializes in prostate cancer. At the PCRI we get questions from a variety of sources, and one common recurring theme is “How does prostate cancer work?” And I think that’s a fair question. It’s a mystery to many people. How does it cause illness? Where does it come from?

Whippany, N.J., April 29, 2019 – Bayer today announced the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review to darolutamide for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC). The NDA and Priority Review status were based on data from the Phase III ARAMIS trial in men with nmCRPC (1). Darolutamide is an investigational, nonsteroidal androgen receptor (AR) antagonist with a distinct chemical structure that binds to the receptor, inhibiting the growth of prostate cancer cells.

Hi, I’m Dr. Scholz. I’m a medical oncologist specializing exclusively in prostate cancer and a common question I get is, “Is one type of hormone therapy better than another?”

The answer would be—actually—yes, but it depends on your situation.

In men that have relatively mild situations with their prostate cancer or perhaps if they’re elderly a medicine called Casodex—an anti-androgen—has a lot fewer…

Basically, prostate cancer doesn’t cause any symptoms at all unless the disease is very advanced, and you can prevent coming down with advanced prostate cancer simply by checking PSA on an annual basis. PSA screening is considered standard for…

In this video we’re going to cover Azure prostate cancer that in standard terms is called “high-risk prostate cancer.” I don’t really like that term “high-risk” because it’s suggests that there’s a high-risk of dying which is truly not the case. The high-risk is relative to the other even more innocuous prostate cancer like low-risk and intermediate-risk. High-risk means that there’s a